Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
AIDS Care ; 25(3): 364-77, 2013.
Article in English | MEDLINE | ID: mdl-22774796

ABSTRACT

The purpose of this study was to investigate the effects of stressful life events (SLE) on medication adherence (3 days, 30 days) as mediated by sense of coherence (SOC), self-compassion (SCS), and engagement with the healthcare provider (eHCP) and whether this differed by international site. Data were obtained from a cross-sectional sample of 2082 HIV positive adults between September 2009 and January 2011 from sites in Canada, China, Namibia, Puerto Rico, Thailand, and US. Statistical tests to explore the effects of stressful life events on antiretroviral medication adherence included descriptive statistics, multivariate analysis of variance, analysis of variance with Bonferroni post-hoc analysis, and path analysis. An examination by international site of the relationships between SLE, SCS, SOC, and eHCP with adherence (3 days and 30 days) indicated these combined variables were related to adherence whether 3 days or 30 days to different degrees at the various sites. SLE, SCS, SOC, and eHCP were significant predictors of adherence past 3 days for the United States (p = < 0.001), Canada (p = 0.006), and Namibia (p = 0.019). The combined independent variables were significant predictors of adherence past 30 days only in the United States and Canada. Engagement with the provider was a significant correlate for antiretroviral adherence in most, but not all, of these countries. Thus, the importance of eHCP cannot be overstated. Nonetheless, our findings need to be accompanied by the caveat that research on variables of interest, while enriched by a sample obtained from international sites, may not have the same relationships in each country.


Subject(s)
Life Change Events , Medication Adherence/psychology , Professional-Patient Relations , Adult , Anti-HIV Agents/therapeutic use , Canada , China , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Humans , Male , Medication Adherence/statistics & numerical data , Middle Aged , Multivariate Analysis , Namibia , Puerto Rico , Surveys and Questionnaires , Thailand , United States
2.
AIDS Care ; 22(9): 1159-70, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20824569

ABSTRACT

Depressive symptoms are highly prevalent yet undertreated in people living with HIV/AIDS (PLHAs). As part of a larger study of symptom self-management (N=1217), this study examined the prevalence, correlates, and characteristics (intensity, distress, and impact) of depressive symptoms, and the self-care strategies used to manage those symptoms in PLHAs in five countries. The proportion of respondents from each country in the total sample reporting depressive symptoms in the past week varied and included Colombia (44%), Norway (66%), Puerto Rico (57%), Taiwan (35%), and the USA (56%). Fifty-four percent (n=655) of the total sample reported experiencing depressive symptoms in the past week, with a mean of 4.1 (SD 2.1) days of depression. Mean depression intensity 5.4 (SD 2.7), distressfulness 5.5 (SD 2.86), and impact 5.5 (SD 3.0) were rated on a 1-10 scale. The mean Center for Epidemiologic Studies Depression Scale score for those reporting depressive symptoms was 27 (SD 11; range 3-58), and varied significantly by country. Respondents identified 19 self-care behaviors for depressive symptoms, which fell into six categories: complementary therapies, talking to others, distraction techniques, physical activity, medications, and denial/avoidant coping. The most frequently used strategies varied by country. In the US sample, 33% of the variance in depressive symptoms was predicted by the combination of education, HIV symptoms, psychological and social support, and perceived consequences of HIV disease.


Subject(s)
Depressive Disorder/therapy , HIV Infections/psychology , Self Care/methods , Adaptation, Psychological , Adult , Aged , Aged, 80 and over , Antidepressive Agents/therapeutic use , Colombia/epidemiology , Communication , Complementary Therapies/methods , Depressive Disorder/complications , Female , HIV Infections/diagnosis , HIV Infections/epidemiology , Humans , Male , Middle Aged , Norway/epidemiology , Puerto Rico/epidemiology , Severity of Illness Index , Social Support , Taiwan/epidemiology , United States/epidemiology , Young Adult
3.
AIDS Care ; 19(10): 1266-73, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18071970

ABSTRACT

The prevalence of peripheral neuropathy is frequent in HIV disease and is often associated with antiretroviral therapy. Unhealthy behaviours, particularly substance-use behaviours, are utilized by many HIV-positive individuals to manage neuropathic symptoms. As part of a larger study on self-care for symptoms in HIV disease, this study analyzed the prevalence and characteristics of unhealthy behaviours to self-manage peripheral neuropathy in HIV disease. Sociodemographic and disease-related correlates and unhealthy behaviours were examined in a convenience sample of 1,217 respondents who were recruited from data collection sites in several US cities, Puerto Rico, Colombia, and Taiwan. Results of the study indicated that respondents with peripheral neuropathy (n=450) identified a variety of unhealthy self-care behaviours including injection drug use, oral drug use, smoking cigarettes and alcohol ingestion. Specific unhealthy behaviours that participants reported to alleviate peripheral neuropathy included use of marijuana (n=67), smoking cigarettes (n=139), drinking alcohol (n=81) and street drugs (n=30). A subset of those individuals (n=160), who identified high levels of neuropathy (greater than five on a scale of 1-10), indicated significantly higher use of amphetamines and injection drug use in addition to alcohol use and cigarette smoking. For participants from Norway, substance use (using alcohol: 56%) was one of the most frequent self-management strategies. Implications for clinical practice include assessment and education of persons with HIV for self-care management of the complex symptom of peripheral neuropathy.


Subject(s)
HIV Infections/psychology , Peripheral Nervous System Diseases/therapy , Risk-Taking , Self Care/methods , Adult , Aged , Aged, 80 and over , Alcohol Drinking/epidemiology , Anti-Retroviral Agents/adverse effects , Attitude to Health , Female , Humans , Male , Middle Aged , Norway/epidemiology , Peripheral Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/psychology , Prevalence , Puerto Rico/epidemiology , Risk Factors , Smoking/epidemiology , Substance-Related Disorders/epidemiology , Taiwan/epidemiology , United States/epidemiology
4.
AIDS Care ; 19(2): 179-89, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17364396

ABSTRACT

Peripheral neuropathy is the most common neurological complication in HIV and is often associated with antiretroviral therapy. As part of a larger study on self-care for symptoms in HIV disease, this study analyzed the prevalence and characteristics of peripheral neuropathy in HIV disease, sociodemographic and disease-related correlates and self-care strategies. A convenience sample of 1,217 respondents was recruited from data collection sites in several US cities, Puerto Rico, Colombia and Taiwan. Results of the study indicated that respondents with peripheral neuropathy (n=450) identified 20 self-care behaviors including complementary therapies, use of medications, exercise and rest and/or elevation of extremities. Ratings of frequency and effectiveness were also included. An activities checklist summarized into five categories of self-care behaviors including activities/thoughts, exercise, medications, complementary therapies and substance was used to determine self-care behaviors. Taking a hot bath was the most frequent strategy used by those with peripheral neuropathy (n=292) and received the highest overall rating of effectiveness of any self-management strategies included in this study at 8.1 (scale 1-10). Other self-care strategies to manage this symptom included: staying off the feet (n=258), rubbing the feet with cream (n=177), elevating the feet (n=236), walking (n=262), prescribed anti-epileptic agent (n=80), prescribed analgesics (n=84), over-the-counter medications (n=123), vitamin B (n=122), calcium supplements (n=72), magnesium (n=48), massage (n=156), acupuncture (n=43), reflexology (n=23) and meditation (n=80). Several behaviors that are often deemed unhealthy were included among the strategies reported to alleviate peripheral neuropathy including use of marijuana (n=67), cigarette smoking (n=139), drinking alcohol (n=81) and street drugs (n=30).


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Peripheral Nervous System Diseases/therapy , Self Care/methods , Adult , Aged , Aged, 80 and over , Alcohol Drinking/therapy , Attitude to Health , Colombia/epidemiology , Exercise , Female , Humans , Male , Middle Aged , Nonprescription Drugs/therapeutic use , Peripheral Nervous System Diseases/epidemiology , Prevalence , Puerto Rico/epidemiology , Smoking/therapy , Taiwan/epidemiology , United States/epidemiology
5.
Mem Inst Oswaldo Cruz ; 87 Suppl 3: 235-9, 1992.
Article in English | MEDLINE | ID: mdl-1343696

ABSTRACT

Fluorescence flow cytometry was employed to assess the potential of a vital dye, hydroethidine, for use in the detection and monitoring of the viability of hemoparasites in infected erythrocytes, using Babesia bovis as a model parasite. The studies demonstrated that hydroethidine is taken up by B. bovis and metabolically converted to the DNA binding fluorochrome, ethidium. Following uptake of the dye, erythrocytes containing viable parasites were readily distinguished and quantitated. Timed studies with the parasiticidal drug, Ganaseg, showed that it is possible to use the fluorochrome assay to monitor the effects of the drug on the rate of replication and viability of B. bovis in culture. The assay provides a rapid method for evaluation of the in vitro effect of drugs on hemoparasites and for analysis of the effect of various components of the immune response, such as lymphokines, monocyte products, antibodies, and effector cells (T, NK, LAK, ADCC) on the growth and viability of intraerythrocytic parasites.


Subject(s)
Babesia bovis/isolation & purification , Erythrocytes/parasitology , Flow Cytometry , Phenanthridines , Animals , Antiprotozoal Agents/pharmacology , Babesia bovis/drug effects , Cattle , Cell Survival , DNA, Protozoan/blood , Diminazene/analogs & derivatives , Diminazene/pharmacology , Ethidium , Parasitology/methods , Phenanthridines/pharmacokinetics
6.
Mem. Inst. Oswaldo Cruz ; 87(supl.3): 235-9, 1992. tab, ilus
Article in English | LILACS | ID: lil-121108

ABSTRACT

Fluorescence flow cytometry was employed to assess the potential of a vital dye, hydroethiedine, for use in the detection and monitoring of the viability of hemoparasites in infected erythrocytes, using Babesia bovis as a model parasite. The studies demonstrated that hydroethidine is taken up by B. bovis and metabolically converted to the DNA binding fluorochrone, ethidium. Following uptake of the dye, erythrocytes contamine viable parasites were readily distinguished and quantitated. Timed studies with the parasiticidal drug, Ganaseg, showed that it is possible to use the fluorochrome assay to monitor the effects of the drug on the rate of replication and viability of B. bovis in culture. The assay provides a rapid method for evaluation of the in vitro effect of drugs on hemoparasites and for analysis of the effect of various components of the immune response, such as lymphokines, monocyte products, antibodies, and effector cells (T, NK, LAK, ADCC) on the growth and viability of intraerythrocytic parasites


Subject(s)
Babesia/analysis , Flow Cytometry , Fluorescence/statistics & numerical data , In Vitro Techniques , Babesia/immunology , Babesia/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL